FGF1 exhibited strong anti-inflammatory and antisteatotic effects in ob/ob mice that were associated with nonalcoholic fatty liver disease (NAFLD) [23]. The gene discussed is FGF1; the disease is metabolic dysfunction-associated steatotic liver disease.